Diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged 40–59 years, both genders; and length of residence in the Lingnan region (Guangdong, Guangxi, Hainan, Hong Kong, Macao) >=5 years. (2) Meet the diagnostic criteria for prediabetes (fasting plasma glucose 6.1–7.0 mmol/L, or 2-hour plasma glucose 7.8–11.0 mmol/L during an oral glucose tolerance test, or HbA1c 5.7%–6.5%). (3) Daily Lingnan Dietary Index (LDI) score <=50 (assessed by the Lingnan Dietary Frequency Questionnaire). (4) Have not participated in other dietary intervention studies in the past 3 months. (5) Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Severe cardiac, hepatic, or renal dysfunction. (2) Digestive system diseases (inflammatory bowel disease, chronic diarrhea, history of gastrointestinal surgery), gout, or severe hyperuricemia. (3) Allergy or intolerance to aquatic products or Lingnan-characteristic vegetables (e.g., bitter melon, okra, etc.). (4) Alcoholism. (5) Use of antibiotics, probiotics/prebiotics, or glucocorticoids within the past 3 months. (6) Pregnancy, lactation, or planning to become pregnant during the study period. (7) Concurrent participation in another clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Plasma Glucose;60-minute Plasma Glucose;120-minute Plasma Glucose;Fasting Insulin;Hemoglobin A1c;Glycated Albumin;Homeostatic Model Assessment of Insulin Resistance;Homeostatic Model Assessment of ß?cell Function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Creatinine;Blood Urea Nitrogen;Uric Acid;Total Cholesterol;Triglycerides;High?Density Lipoprotein Cholesterol;Low?Density Lipoprotein Cholesterol;Plasma untargeted metabolomics;Fecal untargeted metabolomics;Fecal metagenomics;Determination of serum magnesium; | — |
Countries
China
Contacts
Guangdong Provincial Center for Disease Control and Prevention